RETA

Reata Pharmaceuticals, Inc. Class A Common Stock
RETA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

RETA was delisted on the 25th of September, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
–
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$2.93M
2
-$51.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
DekaBank Deutsche Girozentrale
1
DekaBank Deutsche Girozentrale
Germany
–
IA
2
IFP Advisors
Florida
–